publication venue for Potential anti-acanthamoebic effects through inhibition of CYP51 by novel quinazolinones. 231:106440. 2022 Anti-amoebic potential of azole scaffolds and nanoparticles against pathogenic Acanthamoeba. 211:105618. 2020
